SRx Health shares surge 10.33% intraday after launching EventHorizonIQ subscription with EMJX, offering institutional-grade cross-asset regime intelligence.
ByAinvest
Monday, Mar 9, 2026 12:57 pm ET1min read
SRXH--
SRx Health Solutions surged 10.33% intraday trading following the announcement of its newly launched EventHorizonIQ subscription, a cross-asset regime intelligence system developed in collaboration with EMJX. The service provides institutional-grade market insights using 22+ quantitative sensors to monitor macroeconomic, crypto-native, and behavioral signals, with all data logged to an immutable ledger. The product, described as EMJX’s first proprietary offering under its digital asset treasury platform, positions SRx Health as an innovator in AI-driven financial infrastructure. The platform’s focus on real-time market regime classification—rather than predictive analytics—resonates with risk professionals and investors seeking transparent, auditable market diagnostics. The launch directly aligns with the stock’s intraday rally, signaling market optimism over the company’s expanded capabilities and strategic partnership.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet